Keratoconus and
Corneal Cross-linking
Stabilising your vision for the future
Specialist assessment and personalised treatment for keratoconus, including corneal cross-linking (CXL), to strengthen the cornea and help prevent further progression.
Book a consultation →What is keratoconus?
Keratoconus is a condition where the cornea gradually becomes thinner and more cone-shaped. This can cause blurred or distorted vision, increasing short-sightedness and astigmatism. It often begins in the teenage years or early adulthood.
In many people the condition progresses slowly, but in some it can worsen over time and affect vision more significantly. Regular monitoring helps detect changes and guide treatment decisions.
How can corneal cross-linking help?
Corneal cross-linking uses riboflavin (vitamin B2) and ultraviolet A light to strengthen bonds within the cornea. Its main purpose is to stop or slow further progression of keratoconus, potentially reducing the risk of future corneal transplantation.
the cornea
progression
for the future
Who is suitable?
Cross-linking is often recommended when keratoconus is progressing, particularly in younger patients. Decisions are guided by corneal shape, thickness, changes over time and overall eye health.
A detailed assessment, including corneal topography or tomography, will help determine whether cross-linking is appropriate for you.
You may be suitable if you:
- Have keratoconus or another form of corneal ectasia
- Show evidence of progression, or have a higher risk of progression
- Have a cornea suitable for the planned treatment protocol
- Would benefit from reducing the risk of further deterioration
- Have discussed the expected benefits and potential risks
What happens during the procedure?
Corneal cross-linking is usually performed as a day-case procedure. The exact steps and duration depend on the technique used.
Assessment and preparation
Measurements are reviewed and the eye is prepared for treatment.
Numbing drops
Anaesthetic eye drops are used to minimise discomfort.
Riboflavin drops
Vitamin B2 drops are applied to the cornea.
UV light treatment
Controlled ultraviolet A light activates the riboflavin to strengthen the cornea.
Protective contact lens
A bandage lens may be fitted to support healing, depending on the technique.
Recovery and results
After treatment, vision may be blurred, and discomfort, watering or light sensitivity can occur during early healing. Recovery depends on the technique and individual patient; vision may fluctuate for several weeks.
The primary aim is to stabilise keratoconus, not necessarily to improve eyesight or remove the need for glasses or contact lenses. Regular follow-up and corneal imaging are important.
Frequently asked questions
Is corneal cross-linking painful?
Anaesthetic drops are used during treatment. Discomfort, watering and light sensitivity can occur afterwards, particularly with epithelium-off cross-linking.
What are the risks?
Possible risks include infection, delayed healing, corneal haze or scarring, and changes in vision. Rarely, vision may worsen. Your surgeon will discuss your individual risks.
How successful is the treatment?
Most appropriately selected patients achieve stabilisation, but no treatment guarantees that progression will stop. Monitoring remains essential.
How long does the effect last?
The effect is often long-lasting, although progression can occasionally recur and further treatment may be considered in selected cases.
Will my vision improve?
Some patients experience visual changes or modest improvement, but cross-linking is primarily intended to stabilise the cornea. Glasses or specialist contact lenses may still be needed.
Can both eyes be treated?
Both eyes can be assessed, but the decision to treat one or both and the timing depend on progression, clinical findings and the treatment protocol.
Ready to discuss keratoconus treatment?
Arrange a personalised consultation with Mr Ahmed Hussien in Newcastle to review your corneal scans and discuss the most appropriate options for your eyes.
Book a consultation →